Acute Lymphoblastic Leukemia, Pediatric Recruiting Phase 1 / 2 Trials for Fludarabine (DB01073)

Also known as: Pediatric Acute Lymphoblastic Leukemia / Acute Lymphoblastic Leukemia in Pediatric / Pediatric Patients With Acute Lymphoblastic Leukemia / Leukemia, Lymphoblastic, Acute, Pediatric

IndicationStatusPhase
DBCOND0081765 (Acute Lymphoblastic Leukemia, Pediatric)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03676504Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CARTreatment